Plain-English translation of NCT05447169 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing several different blood tests and tissue samples to find the best way to detect early signs of nasopharyngeal cancer in people at high risk. This study focuses on men in Southern China whose close relatives have had this cancer. The goal is to figure out which screening method works best so doctors can catch cancer earlier in people who are most likely to develop it.
Nasopharyngeal cancer is more common in certain families and populations. Currently, there is no standard screening test for people at high risk. This study exists to find the most accurate and practical way to detect the disease early, when treatment is most effective.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will provide samples from your throat (a simple brush) and blood samples so researchers can test them using different laboratory methods. The study will compare these different testing approaches to determine which one best identifies people at risk. You will likely have one or a small number of visits to provide these samples, though the exact timeline should be confirmed with the research team.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
China
Collaborators
Wuzhou Red Cross Hospital, Zhongshan People's Hospital, Guangdong, China
Enrollment target
~11,625 participants
Started
July 2022
Primary completion
July 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
30 Years – 62 Years
Sex
Male only
Last updated on clinicaltrials.gov in July 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ming-Yuan Chen, MD, PhD
Sun Yat-sen University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.